Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
Open Access
- 1 February 2019
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 40, 394-405
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe (110972, 70113213)
- PiPAC Consortium (70112505)
- German Academic Exchange Service
- Deutsche Forschungsgemeinschaft (JO 815/3-2)
- Else-Kröner-Fresenius-Stiftung
This publication has 39 references indexed in Scilit:
- Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminaseOncogene, 2013
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerProceedings of the National Academy of Sciences, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- nab-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic CancerCancer Discovery, 2012
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Advanced pancreatic carcinoma: current treatment and future challengesNature Reviews Clinical Oncology, 2010
- Cellular pharmacology of gemcitabineAnnals of Oncology, 2006
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005
- Mammalian 5′-NucleotidasesJournal of Biological Chemistry, 2003
- Human Cytosolic 5′-Nucleotidase IJournal of Biological Chemistry, 2001